Correction of persistent thrombocytopenia by a boost of CD133+ selected stem cells in a patient transplanted for Wiskott-Aldrich syndrome 10 years ago

This publication has 10 references indexed in Scilit:

• Transplantation of a combination of CD133⁺ and CD34⁺ selected progenitor cells from alternative donors
  British Journal of Haematology, 2003
• Megakaryocyte chimerism after allogeneic stem cell transplantation in children
  Pediatric Transplantation, 2003
• Quantitative analysis of chimerism after allogeneic stem cell transplantation by PCR amplification of microsatellite markers and capillary electrophoresis with fluorescence detection: the Tuebingen experience
  Leukemia, 2003
• Normal human bone marrow CD34+CD133+ cells contain primitive cells able to produce different categories of colony-forming unit megakaryocytes in vitro
  Experimental Hematology, 2002
• Mixed chimera status of 12 patients with Wiskott-Aldrich syndrome (WAS) after hematopoietic stem cell transplantation: evaluation by flow cytometric analysis of intracellular WAS protein expression
  Blood, 2002
• Impact of donor type on outcome of bone marrow transplantation for Wiskott-Aldrich syndrome: collaborative study of the International Bone Marrow Transplant Registry and the National Marrow Donor Program.
  Blood, 2001
• Serial and quantitative analysis of mixed hematopoietic chimerism by PCR in patients with acute leukemias allows the prediction of relapse after allogeneic BMT
  Bone Marrow Transplantation, 1998
• Bone marrow transplantation in 26 patients with Wiskott-Aldrich syndrome from a single center
  The Journal of Pediatrics, 1996
• Isolation of a novel gene mutated in Wiskott-Aldrich syndrome
  Cell, 1994
• Reduction of graft failure by a monoclonal antibody (anti-LFA-1 CD11a) after HLA nonidentical bone marrow transplantation in children with immunodeficiencies, osteopetrosis, and Fanconi's anemia: a European Group for Immunodeficiency/European Group for Bone Marrow Transplantation report
  Blood, 1991